We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Media OC Replay Osteoporosis Canada’s REPLAY features some of our most popular online content on bone health and managing osteoporosis. VIEW Unbreakable – The OC Podcast UNBREAKABLE – The OC […]

Volunteer Become an Osteoporosis Canada Volunteer Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals and communities on […]

Osteoporosis Canada’s overall position statement in response to this study: This study did not specifically address the vitamin D requirements of individuals with osteoporosis, those with risk factors for osteoporotic […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

There is no excerpt because this is a protected post.

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

Osteoporosis Canada hosted 60 delegates from all 10 provinces at FLS Forum 2017 on February 25th and 26th in Toronto. Current evidence on models to close the post-fracture care gap was presented and delegates […]